Drug or technology
3 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
AUG 4, 2026 · JOURNAL ARTICLE
Human Vaccines & Immunotherapeutics
A sound comparative immunogenicity study in a vulnerable population showing equivalent responses between two widely used vaccines, but limited by cross-sectional design, surrogate endpoints, and lack of clinical outcome data.
JUL 20, 2026 · JOURNAL ARTICLE
Human Vaccines & Immunotherapeutics
Network meta-analysis of 17 trials confirms differential serotype-specific immunogenicity between higher-valent pneumococcal vaccines, with PCV15 showing mostly superior responses.
JUN 11, 2026 · JOURNAL ARTICLE
Human Vaccines & Immunotherapeutics
Phase 1/2 trial demonstrating that AS03-adjuvanted H5N8 vaccine met FDA immunogenicity criteria with acceptable safety in adults, but lacks efficacy data and comparative effectiveness evidence needed for practice-changing claims.